<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Objective: To describe the metabolic phenotype of type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> in youth and possible metabolic defects leading to its development with particular emphasis on <z:hpo ids='HP_0001397'>fatty liver</z:hpo>.Methods: We present data gathered from studies performed in <z:mp ids='MP_0001261'>obese</z:mp> adolescents across the spectrum of <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance to assess both alterations in insulin sensitivity and secretion </plain></SENT>
<SENT sid="1" pm="."><plain>Discussion regarding treatment options is presented using the data from the Treatment Options for Type 2 <z:mp ids='MP_0002055'>Diabetes</z:mp> in Adolescents and Youth (TODAY) study.Results: As the number of children with <z:hpo ids='HP_0001513'>obesity</z:hpo> continues to grow, the health implications of the condition are becoming increasingly evident </plain></SENT>
<SENT sid="2" pm="."><plain>An unprecedented phenomenon rarely seen before has emerged: type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>At the time of <z:mp ids='MP_0002055'>diabetes</z:mp> diagnosis, <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> may already be present, even in young adults </plain></SENT>
<SENT sid="4" pm="."><plain>The progression from <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in adults occurs through an intermediate phase of altered <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism known as <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> or <z:e sem="disease" ids="C0362046" disease_type="Disease or Syndrome" abbrv="">prediabetes</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Previous studies from our group and others reported a high prevalence of <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> among children and adolescents with marked <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Cross-sectional studies demonstrate that <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> in <z:mp ids='MP_0001261'>obese</z:mp> youth is associated with severe <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, Î²-cell dysfunction, and altered abdominal and muscle fat partitioning </plain></SENT>
<SENT sid="7" pm="."><plain>We end briefly by discussing the current data available on treatment of this condition from the TODAY study, the largest clinical trial ever performed in youth with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>.Conclusion: The observed <z:hpo ids='HP_0003678'>rapid progression</z:hpo> of the <z:chebi fb="105" ids="17234">glucose</z:chebi> homeostasis alterations in adolescents underlines the importance of focusing attention on the earliest stages of the disease before the <z:hpo ids='HP_0003674'>onset</z:hpo> of any alterations in <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance </plain></SENT>
</text></document>